On March 28th, 2024, BioTroy was awarded as one of the "2023 Top 15 Chinese Innovative and Emerging Pharmaceutical Enterprise" by PHARMCUBE, which is one of the top Medical data service provider in China.
The selection of this ranking is based on the innovation capability, R&D progress, and Financing Ability of the company.
Dr. Xu Jie, Founder and Chief Scientist of BioTroy Therapeutics, attended the conference and accepted the award.
